Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Classical Antagonist vs Agonist Stop Protocol in PCOS Women Undergoing ICSI
NCT04094467Phase 4Unknown
- Sponsor
- Assiut University
- Start
- Dec 2019
- Primary completion
- Oct 2020
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of cetrorelix and leuprolide in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Assiut University. Primary endpoint: Clinical pregnancy rate at 6 weeks. Status: unknown.
02
Drugs
cetrorelixleuprolide
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT04094467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04094467.